Michael G. Combs
Known title: CEO & PresidentCIK: 0001641248
Associated companies
Transaction History
| CRVL | ▼ Sell | Open Market | 500 | $30K | 6/12/2026 | View on chart |
| CRVL | ▼ Sell | Open Market | 7,000 | $424K | 6/11/2026 | View on chart |
| CRVL | ▼ Sell | Open Market | 7,000 | $430K | 6/10/2026 | View on chart |
| CRVL | ▼ Sell | Open Market | 7,000 | $426K | 6/9/2026 | View on chart |
| CRVL | ▼ Sell | Open Market | 7,000 | $422K | 6/8/2026 | View on chart |
| CRVL | ▲ Buy | Grant | 62 | $3K | 3/31/2026 | View on chart |
| CRVL | ▼ Sell | Open Market | 8,013 | $433K | 3/9/2026 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 27,750 | $1.4M | 1/5/2026 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 21,175 | $1.4M | 1/5/2026 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,306 | $157K | 1/5/2026 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 156 | $5K | 1/5/2026 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 78 | $5K | 1/5/2026 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 29 | $2K | 1/5/2026 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 501 | $20K | 1/5/2026 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 292 | $20K | 1/5/2026 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 79 | $5K | 1/5/2026 | View on chart |
| CRVL | ▲ Buy | Grant | 44 | $3K | 9/30/2025 | View on chart |
| CRVL | ▼ Sell | Open Market | 2,816 | $316K | 6/3/2025 | View on chart |
| CRVL | ▲ Buy | Grant | 30 | $3K | 3/31/2025 | View on chart |
| CRVL | ▲ Buy | Grant | 30 | $3K | 3/31/2025 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 5,499 | $219K | 1/6/2025 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,008 | $219K | 1/6/2025 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,286 | $140K | 1/6/2025 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 7,344 | $253K | 1/6/2025 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,319 | $253K | 1/6/2025 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,745 | $190K | 1/6/2025 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 1,200 | $21K | 1/6/2025 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 193 | $21K | 1/6/2025 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 396 | $43K | 1/6/2025 | View on chart |
| CRVL | ▼ Sell | Open Market | 2,886 | $1.0M | 11/11/2024 | View on chart |
| CRVL | ▼ Sell | Gift | 106 | $0 | 11/11/2024 | View on chart |
| CRVL | ▼ Sell | Gift | 194 | $0 | 11/11/2024 | View on chart |
| CRVL | ▲ Buy | Grant | 10 | $3K | 9/30/2024 | View on chart |
| CRVL | ▼ Sell | Open Market | 2,473 | $744K | 8/12/2024 | View on chart |
| CRVL | ▲ Buy | Grant | 13 | $3K | 3/28/2024 | View on chart |
| CRVL | ▼ Sell | Open Market | 1,799 | $447K | 2/15/2024 | View on chart |
| CRVL | ▼ Sell | Open Market | 301 | $74K | 2/13/2024 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 6,000 | $526K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,240 | $526K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,855 | $436K | 2/5/2024 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 4,500 | $395K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,680 | $395K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,391 | $327K | 2/5/2024 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 4,500 | $395K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,680 | $395K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,391 | $327K | 2/5/2024 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 5,600 | $295K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,256 | $295K | 2/5/2024 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,570 | $369K | 2/5/2024 | View on chart |
| CRVL | ▲ Buy | Grant | 17 | $3K | 9/29/2023 | View on chart |
| CRVL | ▼ Sell | Open Market | 4,130 | $920K | 8/11/2023 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 6,000 | $421K | 5/12/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,923 | $421K | 5/12/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,012 | $441K | 5/12/2023 | View on chart |
| CRVL | ▲ Buy | Grant | 17 | $3K | 3/31/2023 | View on chart |
| CRVL | ▼ Sell | Open Market | 1,850 | $341K | 2/16/2023 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 6,400 | $499K | 2/9/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,756 | $499K | 2/9/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,579 | $286K | 2/9/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 716 | $101K | 1/5/2023 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 1,250 | $62K | 1/5/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 437 | $62K | 1/5/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 313 | $44K | 1/5/2023 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 1,250 | $72K | 1/5/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 508 | $72K | 1/5/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 256 | $36K | 1/5/2023 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 3,999 | $312K | 1/5/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,210 | $312K | 1/5/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 596 | $84K | 1/5/2023 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 4,800 | $374K | 1/5/2023 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,652 | $374K | 1/5/2023 | View on chart |
| CRVL | ▲ Buy | Grant | 26 | $3K | 9/30/2022 | View on chart |
| CRVL | ▼ Sell | Open Market | 1,640 | $263K | 8/8/2022 | View on chart |
| CRVL | ▼ Sell | Open Market | 772 | $125K | 8/5/2022 | View on chart |
| CRVL | ▼ Sell | Open Market | 588 | $83K | 6/10/2022 | View on chart |
| CRVL | ▲ Buy | Grant | 20 | $3K | 3/31/2022 | View on chart |
| CRVL | ▼ Sell | Open Market | 4,229 | $687K | 2/23/2022 | View on chart |
| CRVL | ▼ Sell | Open Market | 200 | $33K | 2/22/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,211 | $192K | 2/11/2022 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 6,400 | $380K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,391 | $380K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,938 | $308K | 2/11/2022 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 18,750 | $926K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 5,835 | $926K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 5,388 | $855K | 2/11/2022 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 8,750 | $502K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 3,161 | $502K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 2,703 | $429K | 2/11/2022 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 3,286 | $195K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,227 | $195K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 995 | $158K | 2/11/2022 | View on chart |
| CRVL | ▲ Buy | Option Exercise | 3,999 | $237K | 2/11/2022 | View on chart |
| CRVL | ▼ Sell | Tax Withholding | 1,494 | $237K | 2/11/2022 | View on chart |
| CRVL | ▲ Buy | Grant | 18 | $3K | 9/30/2021 | View on chart |
| CRVL | ▼ Sell | Open Market | 560 | $90K | 8/23/2021 | View on chart |
| CRVL | ▼ Sell | Open Market | 2,440 | $385K | 8/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
CRVL Featured Among Top AI Healthcare Stocks in Yahoo Article
CRVL was highlighted as one of the top AI‑driven healthcare stocks in a recent Yahoo article. The mention underscores the company’s growing focus on artificial intelligence solutions for the medical sector. Analysts note that this exposure could increase visibility among investors interested in AI‑enabled healthcare. The stock remains in a high‑range area of its 52‑week cycle.
CRVL Featured Among Top AI Healthcare Stocks in Yahoo Article. CRVL was highlighted as one of the top AI‑driven healthcare stocks in a recent Yahoo article. The mention underscores the company’s growing focus on artificial intelligence solutions for the medical sector. Analysts note that this exposure could increase visibility among investors interested in AI‑enabled healthcare. The stock remains in a high‑range area of its 52‑week cycle.